Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
ACVR2B - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 498 | 498 |
|
Centogene AG - the Rare Disease Company Germany | 499 | 499 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Congenital Anomalies of the Gastrointestinal Tract Panel PreventionGenetics, part of Exact Sciences United States | 297 | 180 |
|
Heterotaxy, Situs Inversus and Kartagener's Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 43 | 48 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Heterotaxy, visceral, 4, autosomal, 613751; HTX4 (Heterotaxia) (Prenatal) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Heterotaxy, visceral, 4, autosomal, 613751; HTX4 (Heterotaxia) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Congenital Heart Disease Panel Invitae United States | 107 | 55 |
|
Heterotaxy, Visceral 4 (HTX4) via the ACVR2B Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 135 | 133 |
|
Heterotaxy visceral 4, autosomal (sequence analysis of ACVR2B gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Congenital structural heart disease panel. NGS panel of 62 genes. Genologica Medica Spain | 113 | 62 |
|
Ciliopathy panel. NGS panel of 99 genes. Genologica Medica Spain | 152 | 97 |
|
Heterotaxy and situs inversus panel. 32-gene NGS panel. Genologica Medica Spain | 34 | 31 |
|
Asper Biogene Asper Biogene LLC Estonia | 166 | 120 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.